These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 15553013)

  • 1. Prediction of tumor control by tumor regression at 40 Gy/4 weeks of external beam irradiation for oropharyngeal carcinoma.
    Ohizumi Y; Tamai Y; Imamiya S; Akiba T
    Radiat Med; 2004; 22(5):324-31. PubMed ID: 15553013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Epidermoid carcinomas of anal canal treated with radiation therapy and concomitant chemotherapy (5-fluorouracil and cisplatin)].
    Deniaud-Alexandre E; Touboul E; Tiret E; Sezeur A; Hannoun L; Houry S; Huguet F; Pène F; Parc R; Schlienger M
    Cancer Radiother; 2006 Dec; 10(8):572-82. PubMed ID: 17110148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Survival status of stage IV non-small cell lung cancer patients after radiotherapy--a report of 287 cases].
    Cai Y; Wang WL; Xu B; Zhu GY; Zhang SW
    Ai Zheng; 2006 Nov; 25(11):1419-22. PubMed ID: 17094913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inoperable oropharyngeal carcinoma treated with concomitant irradiation, mitomycin C and bleomycin - long term results.
    Budihna M; Soba E; Smid L; Zakotnik B; Strojan P; Cemazar M; Fajdiga I; Zargi M; Zupevc A; Lesnicar H
    Neoplasma; 2005; 52(2):165-74. PubMed ID: 15800716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Esophagectomy after concurrent chemoradiotherapy improves locoregional control in clinical stage II or III esophageal cancer patients.
    Liao Z; Zhang Z; Jin J; Ajani JA; Swisher SG; Stevens CW; Ho L; Smythe R; Vaporciyan AA; Putnam JB; Walsh GL; Roth JA; Yao JC; Allen PK; Cox JD; Komaki R
    Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1484-93. PubMed ID: 15590179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of prognostic factors in patients with oropharyngeal squamous cell carcinoma treated with radiotherapy alone or in combination with systemic chemotherapy.
    Pedruzzi PA; Kowalski LP; Nishimoto IN; Oliveira BV; Tironi F; Ramos GH
    Arch Otolaryngol Head Neck Surg; 2008 Nov; 134(11):1196-204. PubMed ID: 19015451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of oropharyngeal squamous cell carcinoma with external beam radiation combined with interstitial brachytherapy.
    Chen J; Pappas L; Moeller JH; Rankin J; Sharma PK; Bentz BG; Fang LC; Hayes JK; Shrieve DC; Hitchcock YJ
    Head Neck; 2007 Apr; 29(4):362-9. PubMed ID: 17163468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Follow-up study of clinical effects of californium-252 neutron intracavitary radiotherapy and external beam radiotherapy in endometrial cancer].
    Lei X; Shan JL; Tang C; Zhao KW
    Zhonghua Fu Chan Ke Za Zhi; 2007 Nov; 42(11):733-6. PubMed ID: 18307897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-dose-rate brachytherapy in uterine cervical carcinoma.
    Patel FD; Rai B; Mallick I; Sharma SC
    Int J Radiat Oncol Biol Phys; 2005 May; 62(1):125-30. PubMed ID: 15850912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma--the University of Iowa experience.
    Yao M; Dornfeld KJ; Buatti JM; Skwarchuk M; Tan H; Nguyen T; Wacha J; Bayouth JE; Funk GF; Smith RB; Graham SM; Chang K; Hoffman HT
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):410-21. PubMed ID: 16168834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intensity-modulated radiation therapy for the treatment of oropharyngeal carcinoma: the Memorial Sloan-Kettering Cancer Center experience.
    de Arruda FF; Puri DR; Zhung J; Narayana A; Wolden S; Hunt M; Stambuk H; Pfister D; Kraus D; Shaha A; Shah J; Lee NY
    Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):363-73. PubMed ID: 15925451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retromolar trigone carcinoma treated by primary radiation therapy: an alternative to the primary surgical approach.
    Ayad T; Gélinas M; Guertin L; Larochelle D; Del Vecchio P; Tabet JC; Olivier MJ; Soulières D; Charpentier D; Nguyen-Tân PF
    Arch Otolaryngol Head Neck Surg; 2005 Jul; 131(7):576-82. PubMed ID: 16027279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exclusive radiotherapy for primary squamous cell carcinoma of the vagina.
    de Crevoisier R; Sanfilippo N; Gerbaulet A; Morice P; Pomel C; Castaigne D; Pautier P; Lhomme C; Duvillard P; Haie-meder C
    Radiother Oncol; 2007 Dec; 85(3):362-70. PubMed ID: 17963909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Intensity modulated radiotherapy for local-regional advanced nasopharyngeal carcinoma].
    Zhao C; Han F; Lu LX; Huang SM; Lin CG; Deng XW; Lu TX; Cui NJ
    Ai Zheng; 2004 Nov; 23(11 Suppl):1532-7. PubMed ID: 15566674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Long-term results and prognostic factors of squamous cell carcinoma of the anal canal treated by irradiation].
    Tournier-Rangeard L; Peiffert D; Lafond C; Mege A; Metayer Y; Marchesi V; Buchheit I; Uwer L; Conroy T; Kaminsky MC
    Cancer Radiother; 2007 Jun; 11(4):169-77. PubMed ID: 17400501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose-response relationship in locoregional control for patients with stage II-III esophageal cancer treated with concurrent chemotherapy and radiotherapy.
    Zhang Z; Liao Z; Jin J; Ajani J; Chang JY; Jeter M; Guerrero T; Stevens CW; Swisher S; Ho L; Yao J; Allen P; Cox JD; Komaki R
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):656-64. PubMed ID: 15708243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy: the Hong Kong experience.
    Kam MK; Teo PM; Chau RM; Cheung KY; Choi PH; Kwan WH; Leung SF; Zee B; Chan AT
    Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1440-50. PubMed ID: 15590175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Squamous cell carcinoma of the external auditory canal: long-term clinical outcomes using surgery and external-beam radiotherapy.
    Prabhu R; Hinerman RW; Indelicato DJ; Morris CG; Werning JW; Vaysberg M; Amdur RJ; Kirwan J; Mendenhall WM
    Am J Clin Oncol; 2009 Aug; 32(4):401-4. PubMed ID: 19398900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective phase II trial of concomitant boost radiotherapy for stage II nasopharyngeal carcinoma: an evaluation of response and toxicity.
    Lu JJ; Shakespeare TP; Thiagarajan A; Zhang X; Liang L; Tan S
    Laryngoscope; 2005 May; 115(5):806-10. PubMed ID: 15867644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypoxic versus normoxic external-beam irradiation of cervical carcinoma combined with californium-252 neutron brachytherapy. Comparative treatment results of a 5-year randomized study.
    Tacev T; Vacek A; Ptácková B; Strnad V
    Strahlenther Onkol; 2005 May; 181(5):273-84. PubMed ID: 15900423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.